ASX:RMDHealth Care Equipment & ServicesHealth Care Equipment

RESMED CDI

$35.830

$0.460 (1.27%)

Day Range

$35.630 - $36.050

52 Week Range

$32.040 - $45.250

Volume

894.69K

Market Cap

$20.76B

Price Chart

Market Statistics

Open$36.050

Previous Close$36.290

Day High$36.050

Day Low$35.630

52 Week High$45.250

52 Week Low$32.040

Valuation

Market Cap20.76B

Shares Outstanding579.45M

Trading Activity

Volume894.69K

Value Traded32.03M

Bid$35.830 × 986

Ask$35.850 × 700

Technical Indicators

RSI (14)39.34

50-Day SMA$37.579

200-Day SMA$39.500

Weekly Wrap: Late pullback slams gold shares

ASX slips 0.7% as late pullback drags gold shares lower on Fed chair speculation; bullion drops ~5% amid rate-hike fears.

4 min read

John Beveridge

ASX 200Biotechnology

ResMed delivers double-digit EPS growth on increasing demand for sleep apnoea devices

ResMed (ASX: RMD) has reported double-digit earnings per share (EPS) growth for the three months to March on the back of increasing market demand for its best-in-class sleep apnoea products and software solutions. The company’s revenue for the period increased by 8% to US$1.3 billion (up 9% on a constant currency basis), while income from […]

2 min read

Imelda Cotton

ASX 200Technology

ResMed shares hit as Eli Lilly’s weight loss drug demonstrates sleep apnoea benefits

Medical device maker ResMed (ASX: RMD) saw its shares tumble more than 13% after pharmaceutical rival Eli Lilly announced that its weight-loss drug Zepbound (tirzepatide) could also help resolve sleep apnoea in some patients. California-based ResMed is a giant in the sleep apnoea space, manufacturing face masks, nasal devices and continuous positive airway pressure (PAP) […]

2 min read

Imelda Cotton